The Spectator magazine combines incisive political analysis with books and arts reviews of unrivaled authority. Absolutely free. Go to spectator.com.uk forward slash voucher.

Hello and welcome to Coffeehouse Shots, the Spectator's Daily Politics Podcast.

I'm Isabel Hardman and I'm joined by James Forsyth and Katie Balls.

Well, there's good news from the Bank of England today, which has forecast a rapid recovery

for the economy.

And it's partly down to vaccines, James.

Yes. This is essentially the idea that as people are vaccinated and restrictions are ease, people really will be happy to go out and spend money because they won't be worried about getting the virus because they've had a vaccine. And I think this is, I think the banking report reflects there is a broad belief

that there is quite a lot of pent up demand in the economy. And so that, and households have

been saving considerably more than they normally do. And so when you ease these restrictions,

people are going to go out and spend that money.

Katie, let's look at the vaccines in more detail.

There's been a UK trial that started to look at the mixing of the COVID vaccines.

How significant is that?

Well, I think it just shows how at the moment the UK side is examining all the various things they can do to try and speed up the

programme and also it does raise questions about supply we have had assurances on the EU that the

Pfizer supply will be strong but I think the main reason I'm looking at this is the question is

could it actually mean there was a stronger immune response and I think that if you look at

not yet validation but

one study this week on the ox of vaccine saying that waiting you know 12 weeks onwards is actually

something that will increase the immune response a decision was initially criticized when they said

they were going to do that it does does show you to a degree how trying new

things, because science has moved so quickly in these vaccines, is at a point where I think that

...